Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Progyny stock | $61.27

Learn how to easily invest in Progyny stock.

Progyny Inc is a health information services business based in the US. Progyny shares (PGNY) are listed on the NASDAQ and all prices are listed in US Dollars. Progyny employs 210 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Progyny

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PGNY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Progyny stock price (NASDAQ: PGNY)

Use our graph to track the performance of PGNY stocks over time.

Progyny shares at a glance

Information last updated 2021-10-17.
Latest market close$61.27
52-week range$23.56 - $66.61
50-day moving average $58.44
200-day moving average $55.79
Wall St. target price$70.20
PE ratio 71.8742
Dividend yield N/A (0%)
Earnings per share (TTM) $0.78

Buy Progyny shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Progyny stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Progyny price performance over time

Historical closes compared with the close of $61.27 from 2021-10-21

1 week (2021-10-15) 9.43%
1 month (2021-09-23) -3.48%
3 months (2021-07-23) 8.25%
6 months (2021-04-23) 15.19%
1 year (2020-10-22) 123.61%
2 years (2019-10-19) N/A
3 years (2018-10-19) N/A
5 years (2016-10-19) N/A

Is Progyny under- or over-valued?

Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Progyny's P/E ratio

Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Progyny shares trade at around 72x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Progyny's EBITDA

Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.4 million.

The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.

Progyny financials

Revenue TTM $450 million
Operating margin TTM 8.62%
Gross profit TTM $70.1 million
Return on assets TTM 9.9%
Return on equity TTM 48%
Profit margin 17.29%
Book value $2.29
Market capitalisation $5 billion

TTM: trailing 12 months

Shorting Progyny shares

There are currently 5.1 million Progyny shares held short by investors – that's known as Progyny's "short interest". This figure is 20.3% up from 4.2 million last month.

There are a few different ways that this level of interest in shorting Progyny shares can be evaluated.

Progyny's "short interest ratio" (SIR)

Progyny's "short interest ratio" (SIR) is the quantity of Progyny shares currently shorted divided by the average quantity of Progyny shares traded daily (recently around 1.1 million). Progyny's SIR currently stands at 4.47. In other words for every 100,000 Progyny shares traded daily on the market, roughly 4470 shares are currently held short.

However Progyny's short interest can also be evaluated against the total number of Progyny shares, or, against the total number of tradable Progyny shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Progyny's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Progyny shares in existence, roughly 60 shares are currently held short) or 0.0734% of the tradable shares (for every 100,000 tradable Progyny shares, roughly 73 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Progyny.

Find out more about how you can short Progyny stock.

Progyny share dividends

We're not expecting Progyny to pay a dividend over the next 12 months.

Progyny overview

Progyny, Inc. , a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc.

Frequently asked questions

What percentage of Progyny is owned by insiders or institutions?
Currently 5.291% of Progyny shares are held by insiders and 87.541% by institutions.
How many people work for Progyny?
Latest data suggests 210 work at Progyny.
When does the fiscal year end for Progyny?
Progyny's fiscal year ends in December.
Where is Progyny based?
Progyny's address is: 1359 Broadway, New York, NY, United States, 10018
What is Progyny's ISIN number?
Progyny's international securities identification number is: US74340E1038
What is Progyny's CUSIP number?
Progyny's Committee on Uniform Securities Identification Procedures number is: 74340E103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site